A Study to Understand How the Study Medicine (PF-07976016) is Processed and Eliminated in Healthy Men

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 4, 2025

Primary Completion Date

July 16, 2025

Study Completion Date

August 14, 2025

Conditions

Healthy Male Volunteers

Interventions

DRUG

[14C] PF-07976016

\[14C\] PF-07976016 liquid (oral) formulation

DRUG

PF-07976016

PF-07976016 liquid (oral) formulation

DRUG

[14C] PF-07976016

\[14C\] PF-07976016 intravenous (IV) formulation

Trial Locations (1)

ICON, Groningen